课题基金 / 基金详情

Validation of blocking TSP4/Cava2d1 interaction as a new target for neuropathic pain

Validation of blocking TSP4/Cava2d1 interaction as a new target for neuropathic pain
验证阻断 TSP4/Cava2d1 相互作用作为神经性疼痛的新靶点
批准号:
10552492
负责人:
ZHIGANG David LUO
金额:
$9.59万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-05-01 至 2024-04-30

项目摘要

项目成果

ZHIGANG David LUO的其他基金

相似基金

相关文献

中文摘要
翻译
摘要
英文摘要
Abstract We generate a wide variety of datasets and file types from our current HEAL-Initiative award (1R01DE029202). Since a lot of these individual datasets may not have accepted community standards for transmission to and storage at selected repositories, it is very difficult, if not impossible, for data centralized management and sharing access by others, cross-discoverability, interpretation, reuse, and long-term preservation. To improve our data management and sharing practice, we propose the following: (1) plans for conducting a self-assessment to identify gaps or deficiencies in FAIRness unique to our data based on the guidelines from FAIR Evaluation Services (FAIRSharing.org); (2) Plans for improving data FAIRness and developing or enhancing a data management and sharing plan to be in line with current NIH policies; (3) Steps toward implementing enhanced data management and sharing. Successful completion of the proposal will improve our data FAIRness, data management and sharing practice to ensure in line with the NIH Policy for Data Management and Sharing.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Validation of blocking TSP4/Cava2d1 interaction as a new target for neuropathic pain
  • 批准号:
    10452913
  • 项目类别:
  • 资助金额:
    $7.99万
  • 财政年份:
    2021
  • 负责人:
    ZHIGANG David LUO
  • 依托单位:
Validation of blocking TSP4/Cava2d1 interaction as a new target for neuropathic pain
  • 批准号:
    10670457
  • 项目类别:
  • 资助金额:
    $9.66万
  • 财政年份:
    2019
  • 负责人:
    ZHIGANG David LUO
  • 依托单位:
Nanoparticle mediated in vivo cell-type specific drug delivery for pain relief
  • 批准号:
    8364809
  • 项目类别:
  • 资助金额:
    $22.18万
  • 财政年份:
    2012
  • 负责人:
    ZHIGANG David LUO
  • 依托单位:
Nanoparticle mediated in vivo cell-type specific drug delivery for pain relief
  • 批准号:
    8501694
  • 项目类别:
  • 资助金额:
    $17.39万
  • 财政年份:
    2012
  • 负责人:
    ZHIGANG David LUO
  • 依托单位:
海外基金